Abstract Details

Title A Feasibility Study of Intraventricular Methotrexate by Continuous Infusion Using the Synchromed Infusion System for Leptomeningeal Metastasis

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 018

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
	No disclosure on file
Marco Lima	No disclosure on file
Leila Sellami, MD (CSSS de l'Outaouais Hôpital de Hull)	Dr. Sellami has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Mark Rosenblum	No disclosure on file
Lisa R. Rogers, DO, FAAN (Henry Ford Hospital)	Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Nicolas Dupre, MD, FAAN (CHU de Quebec - U Laval)	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Nicolas Dupre, MD, FAAN (CHU de Quebec - U Laval)	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.

��ɫ��